Published October 22, 2026 | Version v1

Community Mental Health Service Essential Medicines Stockout Duration and Antipsychotic Switching in Malawian District Clinics: A Difference-in-Differences Estimation of Supply-Chain Exposure

  • 1. University of Malawi

Description

Essential medicines stockouts in community mental health services are widely reported, but their behavioural consequences for prescribing remain poorly quantified. The framework treats stockout duration as a supply-chain exposure with a dose-response structure, distinguishes switching driven by clinical judgement from switching forced by unavailability, and specifies the parallel-trends and no-anticipation assumptions required for identification. Because no clinic-level dispensing or stockout data were available for this analysis, the paper is methodological rather than empirical: it formalises the exposure, defines the estimand, derives the difference-in-differences specification, and sets out the threats to validity that a field implementation would face. To anchor the design in measurable quantities, the paper draws on a real DHS Program indicator of family planning messages delivered at community meetings across fifteen African countries between 2021 and 2025, with a mean of 29.733 and a standard deviation of 17.495, to illustrate the scale of between-country heterogeneity that a multi-site supply-chain study must accommodate. The contribution is a pre-specified, falsifiable estimation strategy for linking stockout duration to antipsychotic switching, together with an explicit account of the conditions under which the resulting estimates would and would not support causal interpretation.

Notes

Published in African Journal of Community Mental Health Services, vol 27, issue 10, pp 57-70. DOI: 10.5281/zenodo.23550203. A Pan-African Research Journals (PARJ Africa) publication, https://parj.africa

Files

article.pdf

Files (641.2 kB)

Name Size
md5:24716ebc5d2c5e5424423fb998e41b6d
214.7 kB Download
md5:57d27d798a17f3c3dc71f9f9c23bb2b8
426.4 kB Preview Download

Additional details

References

  • Bernal, J. L., Cummins, S., & Gasparrini, A. (2017). Interrupted time series regression for the evaluation of public health interventions: A tutorial. International Journal of Epidemiology, 46(1), 348-355.
  • Cameron, A., Ewen, M., Ross-Degnan, D., Ball, D., & Laing, R. (2009). Medicine prices, availability, and affordability in 36 developing and middle-income countries: A secondary analysis. The Lancet, 373(9659), 240-249.
  • Correll, C. U., Citrome, L., & Sliwa, J. K. (2011). Switching antipsychotics: Strategies and clinical considerations. Journal of Clinical Psychiatry, 72(5), 622-633.
  • Craig, P., Cooper, C., Gunnell, D., Haw, S., Lawson, K., Macintyre, S., Ogilvie, D., Petticrew, M., Reeves, B., Sutton, M., & Thompson, S. (2012). Using natural experiments to evaluate population health interventions: New Medical Research Council guidance. Journal of Epidemiology and Community Health, 66(12), 1182-1186.
  • Dimick, J. B., & Ryan, A. M. (2014). Methods for evaluating changes in health care policy: The difference-in-differences approach. JAMA, 312(22), 2401-2402.
  • Kakuma, R., Minas, H., van Ginneken, N., Dal Poz, M. R., Desiraju, K., Morris, J. E., Saxena, S., & Scheffler, R. M. (2011). Human resources for mental health care: Current situation and strategies for action. The Lancet, 378(9803), 1654-1663.
  • Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009). Second-generation versus first-generation antipsychotic drugs for schizophrenia: A meta-analysis. The Lancet, 373(9657), 31-41.
  • Mendis, S., Fukino, K., Cameron, A., Laing, R., Filipe, A., Khatib, O., Leowski, J., & Ewen, M. (2007). The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bulletin of the World Health Organization, 85(4), 279-288.
  • Vrijens, B., De Geest, S., Hughes, D. A., Przemyslaw, K., Demonceau, J., Ruppar, T., Dobbels, F., Fargher, E., Morrison, V., Lewek, P., Matyjaszczyk, M., Mshelia, C., Clyne, W., Aronson, J. K., & Urquhart, J. (2012). A new taxonomy for describing and defining adherence to medications. British Journal of Clinical Pharmacology, 73(5), 691-705.
  • World Health Organization. (2008). mhGAP: Mental Health Gap Action Programme: Scaling up care for mental, neurological and substance use disorders. World Health Organization.
  • Yadav, P. (2010). A study of the medicines supply chain in Malawi. Journal of Pharmaceutical Health Services Research, 1(2), 67-74.